Profile
Temre Johnson is currently the Head-Investor Relations & Media Contact at Alpine Immune Sciences, Inc. Prior to this role, Mr. Johnson worked as the Director-Investor Relations & Communications at Mirati Therapeutics, Inc. from 2018 to 2022.
Temre Johnson active positions
| Companies | Position | Start |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Investor Relations Contact | - |
Former positions of Temre Johnson
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Investor Relations Contact | 31/05/2022 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Temre Johnson
